109 related articles for article (PubMed ID: 12406033)
1. Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy.
Blonde L; Rosenstock J; Mooradian AD; Piper BA; Henry D
Diabetes Obes Metab; 2002 Nov; 4(6):368-75. PubMed ID: 12406033
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.
Garber AJ; Larsen J; Schneider SH; Piper BA; Henry D;
Diabetes Obes Metab; 2002 May; 4(3):201-8. PubMed ID: 12047399
[TBL] [Abstract][Full Text] [Related]
3. Effect of glyburide-metformin combination tablet in patients with type 2 diabetes.
Chien HH; Chang CT; Chu NF; Hsieh SH; Huang YY; Lee IT; Lee WJ; Tang YJ; Sheu WH
J Chin Med Assoc; 2007 Nov; 70(11):473-80. PubMed ID: 18063500
[TBL] [Abstract][Full Text] [Related]
4. Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.
Lewin A; Lipetz R; Wu J; Schwartz S
Clin Ther; 2007 May; 29(5):844-855. PubMed ID: 17697903
[TBL] [Abstract][Full Text] [Related]
5. Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.
Davidson JA; Scheen AJ; Howlett HC
Drug Saf; 2004; 27(15):1205-16. PubMed ID: 15588116
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.
Pratley RE; Kipnes MS; Fleck PR; Wilson C; Mekki Q;
Diabetes Obes Metab; 2009 Feb; 11(2):167-76. PubMed ID: 19125778
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients.
Erle G; Lovise S; Stocchiero C; Lora L; Coppini A; Marchetti P; Merante D
Acta Diabetol; 1999 Jun; 36(1-2):61-5. PubMed ID: 10436254
[TBL] [Abstract][Full Text] [Related]
9. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
10. A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
Viberti G; Kahn SE; Greene DA; Herman WH; Zinman B; Holman RR; Haffner SM; Levy D; Lachin JM; Berry RA; Heise MA; Jones NP; Freed MI
Diabetes Care; 2002 Oct; 25(10):1737-43. PubMed ID: 12351470
[TBL] [Abstract][Full Text] [Related]
11. Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study.
Garber AJ; Bruce S; Fiedorek FT
Clin Ther; 2002 Sep; 24(9):1401-13. PubMed ID: 12380632
[TBL] [Abstract][Full Text] [Related]
12. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
Garber A; Klein E; Bruce S; Sankoh S; Mohideen P
Diabetes Obes Metab; 2006 Mar; 8(2):156-63. PubMed ID: 16448519
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
Garber AJ; Donovan DS; Dandona P; Bruce S; Park JS
J Clin Endocrinol Metab; 2003 Aug; 88(8):3598-604. PubMed ID: 12915642
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
[TBL] [Abstract][Full Text] [Related]
15. Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Marre M; Howlett H; Lehert P; Allavoine T
Diabet Med; 2002 Aug; 19(8):673-80. PubMed ID: 12147149
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin.
Reusch J; Stewart MW; Perkins CM; Cirkel DT; Ye J; Perry CR; Reinhardt RR; Bode BW
Diabetes Obes Metab; 2014 Dec; 16(12):1257-64. PubMed ID: 25155146
[TBL] [Abstract][Full Text] [Related]
17. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.
Garber A; Marre M; Blonde L; Allavoine T; Howlett H; Lehert P; Cornes M
Diabetes Obes Metab; 2003 May; 5(3):171-9. PubMed ID: 12681024
[TBL] [Abstract][Full Text] [Related]
18. Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial.
Chacra AR; Tan GH; Apanovitch A; Ravichandran S; List J; Chen R;
Int J Clin Pract; 2009 Sep; 63(9):1395-406. PubMed ID: 19614786
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
DeFronzo RA; Goodman AM
N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.
Hermann LS; Scherstén B; Bitzén PO; Kjellström T; Lindgärde F; Melander A
Diabetes Care; 1994 Oct; 17(10):1100-9. PubMed ID: 7821128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
